Weiner, S A <br/><br/>
A phase II trial of mitomycin, vincristine, bleomycin, and cisplatin (MOBP) as neoadjuvant therapy in high-risk cervical carcinoma.  [electronic resource] 

 -  Gynecologic oncology  May 1988 
 - 1-6 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0090-8258 
<br/><br/><label>Standard No.: </label>10.1016/0090-8258(88)90038-8  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenocarcinoma--drug therapy<br/>Adult<br/>Aged<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Bleomycin--administration & dosage<br/>Carcinoma, Squamous Cell--drug therapy<br/>Cisplatin--administration & dosage<br/>Clinical Trials as Topic<br/>Combined Modality Therapy<br/>Female<br/>Humans<br/>Middle Aged<br/>Mitomycin<br/>Mitomycins--administration & dosage<br/>Neoplasm Staging<br/>Uterine Cervical Neoplasms--drug therapy<br/>Vincristine--administration & dosage